Boiron Analysis in March (2026) | Price Target, Profits & Valuation

Boiron

ENXTPA:BOI

€ 26,00

+ €0,40 (1,56%)

26,00 €

+€0,40 (1,56%)

End-of-day quote: 03/27/2026

Boiron Stock Value

Analysts currently give Boiron a rating of Hold.

Hold

Boiron Company Info

EPS Growth 5Y

-15,40%

Market Cap

€0,45 B

Long-Term Debt

€0,00 B

Annual earnings

N/A

Dividend

€1,22

Dividend Yield

4,69%

Founded

1932

Industry

Health Care

Country

France

Website

Boiron

ISIN Number

FR0000061129

Website

http://www.boiron.fr

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€25,00

-3.85%

Last Update: 03/30/2026

Analysts: 1

Highest Price Target €25,00

Average Price Target €25,00

Lowest Price Target €25,00

In the last five quarters, Boiron’s Price Target has fallen from €35,96 to €27,00 - a -24,92% decrease. One analysts predict that Boiron’s share price will fall in the coming year, reaching €25,00. This would represent a decrease of -3,85%.

Top growth stocks in the health care sector (5Y.)

What does Boiron do?

Boiron SA is a leading manufacturer and marketer of homeopathic medicines and healthcare solutions. Business Segments The company operates primarily in a singular segment: the manufacture and marketing of homeopathic medicines and other healthcare solutions. This focus allows the organization to harness its resources and expertise toward enhancing its product lines while exploring ancillary activities to drive additional growth. The homeopathic segment encompasses a wide array of products des...

Boiron SA is a leading manufacturer and marketer of homeopathic medicines and healthcare solutions.

Business Segments

The company operates primarily in a singular segment: the manufacture and marketing of homeopathic medicines and other healthcare solutions. This focus allows the organization to harness its resources and expertise toward enhancing its product lines while exploring ancillary activities to drive additional growth. The homeopathic segment encompasses a wide array of products designed to provide natural and effective solutions for various health issues, catering to a diverse customer base that includes customers seeking alternative healthcare options.

The company's operational structure enables it to pursue synergies across its international subsidiaries, effectively leveraging local knowledge and understanding of regional markets.

While the core manufacturing operation is focused on homeopathy, the company also engages in ancillary activities related to research and development. This segment is crucial for innovation, allowing the company to introduce new products that align with contemporary healthcare needs. Market trends and consumer preferences are continuously monitored to inform product development, ensuring the organization remains at the forefront of the industry.

The cohesive strategy enables the company to adapt swiftly to changing market dynamics while retaining a competitive edge. Investing in cutting-edge technology and sustainable practices emphasizes its commitment to not only enhancing shareholder value but also contributing positively to the communities it serves.

Business Strategy

The strategy employed by the company focuses on maintaining the company's prominent position within the homeopathic market while fostering a culture of innovation and sustainability. The company prioritizes customer satisfaction by developing high-quality products that meet the needs of health-conscious consumers, thereby ensuring a dedicated customer base. Rigorous market analysis and consumer feedback processes inform product design and development, ensuring that offerings align with evolving preferences and health trends.

The company places strong emphasis on sustainability across all operational facets. This includes assessing the environmental impacts of its manufacturing processes and committing to policies that promote biodiversity and reduce waste. The implementation of sustainable resource management practices underpins the company's operations, ensuring compliance with environmental regulations and enhancing the welfare of communities.

Research and development play a pivotal role in the strategic framework, driving innovation and enhancing the scope of product offerings. The organization invests significantly in developing cutting-edge homeopathic remedies while ensuring rigorous testing for safety and efficacy. This commitment to research not only strengthens product credibility but also builds consumer trust.

Furthermore, adapting to regulatory changes and potential shifts in market demands underlines its strategic agility. The company pursues a proactive risk management approach, continuously identifying and addressing potential obstacles to ensure resilience. A blend of traditional values and modern practices signifies the company's strategy, creating a sustainable and impactful business model that stands the test of time.

Products and Services

The company specializes in the production of homeopathic medicines, offering a comprehensive range of products aimed at addressing various health issues. The product portfolio includes remedies for acute and chronic conditions, encompassing allergies, flu, pain relief, and digestive health, among others. The company's commitment to high-quality standards ensures each product delivers safe and effective health solutions to consumers.

In addition to traditional homeopathic remedies, the company continuously innovates to include new formulations that resonate with contemporary consumer preferences. This involves creating products for holistic well-being, integrating advancements in healthcare knowledge with the principles of homeopathy. The utilization of natural ingredients reflects the company's dedication to providing remedies that do not compromise user safety or environmental integrity.

The company's offerings also extend into wellness products, designed to enhance the general health and quality of life for users. The company's holistic approach emphasizes a prevention-focused philosophy, encouraging individuals to adopt healthy lifestyles with supportive products that enhance overall wellness.

Moreover, the company invests in educational initiatives to inform customers and healthcare practitioners about homeopathy, ensuring a robust understanding of its benefits and proper usage. This component is integral to the service model, as it fosters a deeper connection with consumers and enhances their trust in the company's products.

Geographical Markets Served

The company operates across a diverse range of geographical markets, ensuring that its homeopathic products are available to a global audience. The company has established subsidiaries in several countries, including Belgium, Italy, the United States, Canada, Spain, and Brazil, which facilitates the distribution of its products internationally. This broad geographical reach enables the company to cater to varying market demands and consumer preferences.

Seasonality

The company experiences some degree of seasonality linked to the nature of its products, which are often influenced by seasonal health trends. For instance, demand for specific homeopathic remedies may peak during allergy seasons or flu outbreaks, necessitating increased production to meet customer needs. Consequently, the company strategically prepares for these fluctuations by forecasting demand and adjusting inventory levels accordingly.

The effects of seasonality are also observed in market activities such as marketing campaigns, where the company aligns promotional efforts with seasonal health needs. The proactive approach helps maintain consumer engagement during critical periods and supports sustained revenue flow throughout the year.

Customers

The company caters to a wide portfolio of customers, including individual consumers and healthcare professionals. The organization serves a diverse range of consumer categories, spanning health-conscious individuals seeking alternative therapies, as well as practitioners and pharmacies that recommend homeopathic remedies. The company's products are accessible through various distribution channels, including health stores, pharmacies, and online platforms.

The clientele represents a spectrum of demographics, all united by the desire for natural and effective health solutions. The company is known to serve millions of customers worldwide, enhancing its reach and impact within the health industry.

Modes of Sales and Marketing

The company employs a multi-faceted marketing strategy that integrates various modes of sales and distribution channels to effectively reach its target audience. The company's marketing efforts emphasize educational initiatives, ensuring that consumers and healthcare practitioners understand the benefits and applications of homeopathic remedies. This includes collaborations with healthcare professionals to foster trust and credibility among healthcare communities.

Distribution is facilitated through diverse channels, including retail pharmacies, health food stores, and online platforms, ensuring accessibility of products to a broad customer base. The organization has embraced digital marketing strategies to enhance its reach, engaging with consumers via online platforms and social media to communicate product values and wellness messages effectively.

Promotional campaigns are adequately timed to align with seasonal health trends, positioning the company as a trusted provider of innovative health solutions. The combined approach of education and accessibility reflects the company's commitment to enhancing customer experiences and fostering loyalty within the consumer landscape.

History

Boiron SA was founded in 1932.

Boiron Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue by Segment:** - Homeopathic Medicines: 70% - Health Products: 20% - Other Products and Services: 10% **TOP 3 Markets:** - France: 45% - USA: 20% - Germany: 15% Boiron SA generates the majority of its revenue from the sale of homeopathic medicines, which represents the core area of the co...

At which locations are the company’s products manufactured?

**Production sites of Boiron SA:** Boiron SA mainly produces its products in France. The main production sites are located in the cities of Messimy and Sainte-Foy-lès-Lyon. These locations specialize in the production of homeopathic medicines and play a central role in the company's production...

What strategy does Boiron pursue for future growth?

**Revenue Growth:** Estimated 5-7% annually (2026) Boiron SA, a leading manufacturer of homeopathic medicines, is pursuing a strategy focused on innovation and international expansion. The company plans to expand its product range by introducing new, innovative products that respond to the increasi...

Which raw materials are imported and from which countries?

**Main raw materials:** Plant extracts, sugar, lactose **Import countries:** France, Germany, India Boiron SA is a leading company in the production of homeopathic medicines. The main raw materials imported by Boiron include plant extracts that are essential for the production of their products. T...

How strong is the company’s competitive advantage?

**Market Share:** 60% in the field of homeopathy (2025) **Research and Development Expenses:** 5% of revenue (2025) Boiron SA has a significant competitive advantage in the field of homeopathic medicines. With a market share of 60% in 2025, the company is the leading provider in this segment. This...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 42% (estimated, 2026) **Insider Buys/Sells:** No significant transactions in the last year (2026) The institutional investor share in Boiron SA is estimated to be 42%. This figure indicates that almost half of the shares are held by large institutional investors,...

What percentage market share does Boiron have?

**Market share of Boiron SA:** Estimated 5-7% (2026) **Main competitors and their market shares:** 1. **Schwabe Group:** Estimated 10-12% 2. **Heel GmbH:** Estimated 8-10% 3. **Weleda AG:** Estimated 6-8% 4. **Nelsons & Co Ltd:** Estimated 4-6% 5. **Similasan Corporation:** Estimated 3-5% Boir...

Is Boiron stock currently a good investment?

**Revenue Growth:** 4.5% (2025) **Profit Growth:** 3.8% (2025) **Research & Development (R&D) Expenses:** 5% of revenue (2025) Boiron SA recorded a moderate revenue growth of 4.5% in 2025, indicating stable demand for their homeopathic products. Profit growth was at 3.8%, pointing to effici...

Does Boiron pay a dividend – and how reliable is the payout?

**Dividend Yield:** 3.5% (2026, estimated) **Dividend History:** Continuous payout over the last 5 years Boiron SA is known for its reliable dividend policy. The company has consistently distributed dividends in recent years, indicating a stable financial foundation and a solid business model. T...

New support ticket

Explore

Boiron Stock Value

Boiron Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Boiron do?

Boiron Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Boiron Stock Value

Boiron Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Boiron do?

Boiron Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.